placental ribonuclease inhibitor
RNasin, is a purified human placental ribonuclease inhibitor, known to have antiangiogenic activity through the inhibition of angiogenin and basic fibroblast growth factor
Also Known As:
RI ribonuclease inhibitor protein; RNasin, placental RNase inhibitor; cytosolic ribonuclease inhibitor protein; nuclease inhibitor, RNasin; placental RNase inhibitor; ribonuclease inhibitor (placental); ribonuclease-angiogenin inhibitor
Networked: 8
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Raines, Ronald T:
2 articles
(12/2002 - 03/2002)
|
2. | Almeida, Márcia R:
1 article
(01/2020)
|
3. | Baracat-Pereira, Maria Cristina:
1 article
(01/2020)
|
4. | Bressan, Gustavo C:
1 article
(01/2020)
|
5. | Cunha, Pricila S:
1 article
(01/2020)
|
6. | Fernandes, Kenner M:
1 article
(01/2020)
|
7. | Fietto, Juliana L R:
1 article
(01/2020)
|
8. | Magalhães-Junior, Marcos J:
1 article
(01/2020)
|
9. | Pereira, Lorena K J:
1 article
(01/2020)
|
10. | Santos, Marcus R:
1 article
(01/2020)
|
Related Diseases
Related Drugs and Biologics